Archive for September 2023

Harbinger Health, a startup led by the former FDA head under President Donald Trump, is putting $140 million in new funds to work on a cancer diagnostic. Read More

Boston-based Fenway Sports Group, owner of Liverpool FC and the Boston Red Sox, has sold a minority investment in the soccer club to private equity firm Dynasty Equity. Read More

The co-founders say they are focusing on the relatively new field of climate biotechnology because of biology’s potential uses to improve planetary health. Read More

Within LAB eN², researchers at the affiliated institutions will have the opportunity to tap into Novo and Evotec’s resources to advance their research. Read More

Good morning — here are the five things you need to know: John Hancock’s Fenway Park sign gets a new life, First Republic employees must apply to keep their jobs and our 1-minute survey is about to close. Read More

In the first major announcement by ezCater since its CEO transition over the summer, the corporate catering marketplace struck a deal with Panera Bread. Read More

Pfizer is partnering up with Boston synthetic biology firm Ginkgo Bioworks, plus other life sciences news you may have missed. Read More

The nonprofit has approval to build a 10-story office building on a property near the Roxbury Crossing MBTA station, but it wants to instead put a six-story, 120,000-square-foot apartment building in its place. Read More

Prashanth Mahendra-Rajah was named as the new CFO at the San Fransisco-based ride-hailing giant effective Nov. 13. Read More

The company is seeking to move the sign — which lived in Fenway Park for 20 years — to the company’s U.S. headquarters building in Back Bay. Read More